Welcome to INSUPPORT®
INSUPPORT® was created to provide information aimed at helping appropriate eligible patients with the process of obtaining INDIVIOR medicines.
Please see the full Prescribing Information including BOXED WARNING for Sublocade (buprenorphine) injection for subcutaneous use (CIII), Important Safety Information for Sublocade and Medication Guide for SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use, CIII.
Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program.
- SUBLOCADE is not available in retail pharmacies.
- Your SUBLOCADE injection will only be given to you by a certified healthcare provider.
Please see the full Prescribing Information for Suboxone (buprenorphine and naloxone) Sublingual Film (CIII), Important Safety Information for Suboxone, and Medication Guide for SUBOXONE (buprenorphine and naloxone) Sublingual Film®, CIII.
Please see the full Prescribing Information including BOXED WARNING for Perseris (risperidone) for extended-release injectable suspension and Important Safety Information for PERSERIS® (risperidone) for extended-release injectable suspension.
Drugs like PERSERIS that are used to treat schizophrenia can cause serious side effects, including an increased risk of death in elderly people who are confused, have memory loss, and have lost touch with reality (dementia-related psychosis). PERSERIS is not approved to treat dementia-related psychosis and it has not been studied in elderly people with dementia-related psychosis.